measuregroup/AID36919

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103353735_AID36919_PMID3973904_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103175300_AID36919_PMID3973904_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103216421_AID36919_PMID3973904_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103216390_AID36919_PMID3973904_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103167211_AID36919_PMID3973904_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22086 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22909 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19328 http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID955
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	In vitro inhibitory activity against alpha-2 adrenergic receptor from rat brain minus cerebellum using [3H]clonidine as radioligand
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103175300 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103216421 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103167211 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103353735 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103216390
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID36919

Total number of triples: 18.